Cargando…

Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China

BACKGROUND: Myeloid neoplasms (MN) tend to relapse and deteriorate. Exploring the genomic mutation landscape of MN using next‐generation sequencing (NGS) is a great measure to clarify the mechanism of oncogenesis and progression of MN. METHODS: This multicenter retrospective study investigated 303 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junnan, Pei, Li, Liang, Simin, Xu, Shuangnian, Wang, Yi, Wang, Xiao, Liao, Yi, Zhan, Qian, Cheng, Wei, Yang, Zesong, Tang, Xiaoqiong, Zhang, Hongbin, Xiao, Qing, Chen, Jianbin, Liu, Lin, Wang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166913/ https://www.ncbi.nlm.nih.gov/pubmed/36799265 http://dx.doi.org/10.1002/cam4.5690

Ejemplares similares

Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations
por: Chicano, María, et al.
Publicado: (2021)

Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next‐generation sequencing technique
por: Wang, Rui‐Qi, et al.
Publicado: (2020)

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
por: Carbonell, Diego, et al.
Publicado: (2019)

Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results
por: Yuce Kahraman, Cigdem, et al.
Publicado: (2022)

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms
por: Kim, Borahm, et al.
Publicado: (2019)

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
por: Andrés‐Zayas, Cristina, et al.
Publicado: (2021)

Notch2 inhibits proliferation of chronic myeloid leukemia cells
por: YANG, ZESONG, et al.
Publicado: (2013)

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016)

Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms
por: Sadato, Daichi, et al.
Publicado: (2021)

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
por: Bannon, Sarah A., et al.
Publicado: (2021)

PB2031: NEXT GENERATION SEQUENCING IN MYELOID NEOPLASMS: DEVELOPING WORLD DATA FROM SINGLE CENTRE
por: Anwar, Nida, et al.
Publicado: (2023)

Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms
por: Madaci, Lamia, et al.
Publicado: (2023)

Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
por: Su, Long, et al.
Publicado: (2018)

Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next-generation sequencing
por: Li, Ying, et al.
Publicado: (2019)

Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms
por: Li, Jia, et al.
Publicado: (2022)

Co-occurrence of myeloid neoplasm and plasma cell neoplasm
por: Jum’ah, Husam, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

P1010: PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS HAVE INCREASED NUMBERS OF MYELOID-DERIVED SUPPRESSOR CELLS, AND DECITABINE MAY HAVE A SIGNIFICANT THERAPEUTIC EFFECT IN MPN PATIENTS WITH HIGH MDSCS
por: Feng, Qiutian, et al.
Publicado: (2023)

Blood-based next-generation sequencing analysis of neuroendocrine neoplasms
por: Zakka, Katerina, et al.
Publicado: (2020)

Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms
por: Rosenthal, Sun Hee, et al.
Publicado: (2021)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
por: Li, Xin, et al.
Publicado: (2017)

Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species
por: WEI, CHUNMEI, et al.
Publicado: (2015)

What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
por: Awada, Hussein, et al.
Publicado: (2023)

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience
por: Alduaij, Waleed, et al.
Publicado: (2018)

Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms
por: Bartels, Stephan, et al.
Publicado: (2016)

Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms
por: Sahajpal, Nikhil Shri, et al.
Publicado: (2020)

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms
por: Aguirre-Ruiz, Paula, et al.
Publicado: (2020)

Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis
por: Xu, Shuangnian, et al.
Publicado: (2015)

Next-Generation Sequencing Technologies and Neurogenetic Diseases
por: Sun, Hui, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis
por: Zhu, Jingyi, et al.
Publicado: (2017)

The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies
por: Öz Puyan, Fulya, et al.
Publicado: (2019)

Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR∷ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study
por: Hu, Shiwei, et al.
Publicado: (2022)

Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
por: Wang, Bianhong, et al.
Publicado: (2016)

Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules
por: Tan, Li-Cheng, et al.
Publicado: (2021)

Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing
por: Li, Henan, et al.
Publicado: (2018)

Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing
por: Kirschner, Martin M. J., et al.
Publicado: (2015)

Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms
por: Jumniensuk, Chayanit, et al.
Publicado: (2022)

BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
por: Mroczkowska-Bękarciak, Aleksandra, et al.
Publicado: (2023)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ggd1rtkgs450sscs8ihage0ljn